Whittier Trust Co. raised its holdings in Foundation Medicine Inc (NASDAQ:FMI) by 1.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 44,685 shares of the company’s stock after purchasing an additional 725 shares during the quarter. Whittier Trust Co. owned 0.12% of Foundation Medicine worth $3,048,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of FMI. Schwab Charles Investment Management Inc. boosted its holdings in shares of Foundation Medicine by 9.9% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 60,227 shares of the company’s stock valued at $2,395,000 after purchasing an additional 5,404 shares in the last quarter. Legal & General Group Plc boosted its holdings in shares of Foundation Medicine by 8.6% during the 2nd quarter. Legal & General Group Plc now owns 3,442 shares of the company’s stock valued at $138,000 after acquiring an additional 274 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Foundation Medicine by 8.8% during the 2nd quarter. Wells Fargo & Company MN now owns 11,510 shares of the company’s stock valued at $458,000 after acquiring an additional 931 shares in the last quarter. Teachers Advisors LLC boosted its holdings in shares of Foundation Medicine by 5.5% during the 2nd quarter. Teachers Advisors LLC now owns 25,728 shares of the company’s stock valued at $1,023,000 after acquiring an additional 1,341 shares in the last quarter. Finally, TIAA CREF Investment Management LLC boosted its holdings in shares of Foundation Medicine by 9.8% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 39,000 shares of the company’s stock valued at $1,550,000 after acquiring an additional 3,490 shares in the last quarter. 33.12% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms recently weighed in on FMI. Zacks Investment Research downgraded Foundation Medicine from a “buy” rating to a “sell” rating in a report on Wednesday, January 3rd. BidaskClub downgraded Foundation Medicine from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Goldman Sachs Group began coverage on Foundation Medicine in a report on Monday, January 29th. They set a “neutral” rating and a $73.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $52.25.

In other Foundation Medicine news, Director Michael J. Pellini sold 37,288 shares of Foundation Medicine stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $64.55, for a total transaction of $2,406,940.40. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Evan/ Fa Jones sold 1,400 shares of Foundation Medicine stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $62.05, for a total value of $86,870.00. Following the transaction, the director now directly owns 17,652 shares in the company, valued at $1,095,306.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 228,717 shares of company stock worth $14,987,592. 2.70% of the stock is currently owned by company insiders.

Shares of Foundation Medicine Inc (NASDAQ:FMI) opened at $63.70 on Tuesday. The company has a current ratio of 2.24, a quick ratio of 2.03 and a debt-to-equity ratio of 0.47. Foundation Medicine Inc has a twelve month low of $22.40 and a twelve month high of $75.20. The firm has a market capitalization of $2,310.00, a price-to-earnings ratio of -14.25 and a beta of -0.03.

TRADEMARK VIOLATION NOTICE: “Foundation Medicine Inc (FMI) Shares Bought by Whittier Trust Co.” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/foundation-medicine-inc-fmi-shares-bought-by-whittier-trust-co/1863397.html.

Foundation Medicine Company Profile

Foundation Medicine, Inc is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer.

Want to see what other hedge funds are holding FMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Foundation Medicine Inc (NASDAQ:FMI).

Institutional Ownership by Quarter for Foundation Medicine (NASDAQ:FMI)

Receive News & Ratings for Foundation Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foundation Medicine and related companies with MarketBeat.com's FREE daily email newsletter.